Showing 1 - 20 results of 32 for search 'Marc S. Raab', query time: 0.05s
Refine Results
-
1
Treatment in AL Amyloidosis: Moving towards Individualized and Clone-Directed Therapy by Ute Hegenbart, Marc S. Raab, Stefan O. Schönland
Published 2021-12-01
Article -
2
-
3
Pathway-Directed Therapy in Multiple Myeloma by Lukas John, Maria Theresa Krauth, Klaus Podar, Marc-Steffen Raab
Published 2021-04-01
Article -
4
-
5
-
6
Impact of novel agent therapies on immune cell subsets and infectious complications in patients with relapsed/refractory multiple myeloma by Lukas John, Lukas John, Kaya Miah, Axel Benner, Elias K. Mai, Katharina Kriegsmann, Michael Hundemer, Dorothee Kaudewitz, Carsten Müller-Tidow, Carsten Müller-Tidow, Karin Jordan, Karin Jordan, Hartmut Goldschmidt, Hartmut Goldschmidt, Marc S. Raab, Marc S. Raab, Nicola Giesen
Published 2023-04-01
Article -
7
Can <sup>18</sup>F-NaF PET/CT before Autologous Stem Cell Transplantation Predict Survival in Multiple Myeloma? by Christos Sachpekidis, Annette Kopp-Schneider, Maximilian Merz, Anna Jauch, Marc-Steffen Raab, Hartmut Goldschmidt, Antonia Dimitrakopoulou-Strauss
Published 2020-05-01
Article -
8
Inhibiting PI3K–AKT–mTOR Signaling in Multiple Myeloma-Associated Mesenchymal Stem Cells Impedes the Proliferation of Multiple Myeloma Cells by Luca Heinemann, Klara Maria Möllers, Helal Mohammed Mohammed Ahmed, Lanying Wei, Kaiyan Sun, Subbaiah Chary Nimmagadda, Daria Frank, Anja Baumann, Anja Baumann, Alexandra M. Poos, Alexandra M. Poos, Martin Dugas, Julian Varghese, Marc-Steffen Raab, Marc-Steffen Raab, Cyrus Khandanpour, Cyrus Khandanpour
Published 2022-06-01
Article -
9
The prognostic significance of [18F]FDG PET/CT in multiple myeloma according to novel interpretation criteria (IMPeTUs) by Christos Sachpekidis, Maximilian Merz, Marc-Steffen Raab, Uta Bertsch, Vivienn Weru, Annette Kopp-Schneider, Anna Jauch, Hartmut Goldschmidt, Antonia Dimitrakopoulou-Strauss
Published 2021-10-01
Article -
10
Stem cell collection after lenalidomide, bortezomib and dexamethasone plus elotuzumab or isatuximab in newly diagnosed multiple myeloma patients: a single centre experience from th... by Joseph Kauer, Emma P. Freundt, Anita Schmitt, Niels Weinhold, Elias K. Mai, Carsten Müller-Tidow, Hartmut Goldschmidt, Marc S. Raab, Katharina Kriegsmann, Sandra Sauer
Published 2023-11-01
Article -
11
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Salvage Autologous Stem Cell Transplant with or without Maintenance for Relapsed or Refractory Multiple Myeloma by Marc-Andrea Baertsch, Mathilde Fougereau, Thomas Hielscher, Sandra Sauer, Iris Breitkreutz, Karin Jordan, Carsten Müller-Tidow, Hartmut Goldschmidt, Marc-Steffen Raab, Jens Hillengass, Nicola Giesen
Published 2021-09-01
Article -
12
P801: BASELINE AND EARLY POST-INFUSION BIOMARKERS ASSOCIATED WITH OPTIMAL RESPONSE TO IDECABTAGENE VICLEUCEL (IDE-CEL) IN THE KARMMA-3 STUDY OF TRIPLE-CLASS–EXPOSED RELAPSED AND RE... by Julia Piasecki, Keyur Desai, Carolyn Courtney, Ethan Thompson, James Pratt, Noopur Raje, Krina Patel, Marc S. Raab, Mark Cook, Katy Simonsen, Mihaela Popa Mckiver, Shari Kaiser, Nathan Martin
Published 2023-08-01
Article -
13
CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma—Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance by Anja Seckinger, Jens Hillengass, Martina Emde, Susanne Beck, Christoph Kimmich, Tobias Dittrich, Michael Hundemer, Anna Jauch, Ute Hegenbart, Marc-Steffen Raab, Anthony D. Ho, Stefan Schönland, Dirk Hose
Published 2018-07-01
Article -
14
Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trial by Dirk Hose, Susanne Beck, Hans Salwender, Martina Emde, Uta Bertsch, Christina Kunz, Christoph Scheid, Mathias Hänel, Katja Weisel, Thomas Hielscher, Marc S. Raab, Hartmut Goldschmidt, Anna Jauch, Jérôme Moreaux, Anja Seckinger
Published 2019-06-01
Article -
15
P839: GAIN OF CHROMOSOME 1Q LEADS TO HIGH EXPRESSION OF SNORD78 AND ABERRANT RIBOSOME METHYLATION by Duoduo Zhao, Christian Rohde, Stefanie Göllner, Fengbiao Zhou, Cornelius Pauli, Maximilian Blank, Rafael Zinz, Anna Luise Grab, Alexandra M Poos, Lukas John, Stefanie Huhn, Marc S. Raab, Carsten Müller-Tidow, Niels Weinhold
Published 2023-08-01
Article -
16
P947: TREATMENT PATTERNS AND OUTCOMES OF RE-INDUCTION THERAPIES PRIOR TO STEM CELL TRANSPLANTATION IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA TREATED IN CLINICAL PRACTIC... by Sandra Sauer, Monika Engelhardt, Karolin Trautmann-Grill, Christoph Kimmich, Mathias Hänel, Martin Schmidt-Hieber, Hans Salwender, Carmen Flossmann, Hiltrud Heckmann, Franziska Ertel, Andrea Friederich, Sachin Patel, Sabine Piesch, Barbara Thun, Marc S. Raab
Published 2023-08-01
Article -
17
Daratumumab, Bortezomib, and Dexamethasone for Treatment of Patients with Relapsed or Refractory Multiple Myeloma and Severe Renal Impairment: Results from the Phase 2 GMMG-DANTE T... by Lisa B. Leypoldt, Maria Gavriatopoulou, Britta Besemer, Hans Salwender, Marc S. Raab, Axel Nogai, Cyrus Khandanpour, Volker Runde, Anna Jauch, Manola Zago, Peter Martus, Hartmut Goldschmidt, Carsten Bokemeyer, Meletios A. Dimopoulos, Katja C. Weisel
Published 2023-09-01
Article -
18
Asymmetric Centriole Numbers at Spindle Poles Cause Chromosome Missegregation in Cancer by Marco R. Cosenza, Anna Cazzola, Annik Rossberg, Nicole L. Schieber, Gleb Konotop, Elena Bausch, Alla Slynko, Tim Holland-Letz, Marc S. Raab, Taronish Dubash, Hanno Glimm, Sven Poppelreuther, Christel Herold-Mende, Yannick Schwab, Alwin Krämer
Published 2017-08-01
Article -
19
The prognostic and predictive value of IKZF1 and IKZF3 expression in T-cells in patients with multiple myeloma by Mohamed H. S. Awwad, Katharina Kriegsmann, Julian Plaumann, Michael Benn, Jens Hillengass, Marc S. Raab, Uta Bertsch, Markus Munder, Katja Weisel, Hans Jürgen Salwender, Mathias Hänel, Roland Fenk, Jan Dürig, Carsten Müller-Tidow, Hartmut Goldschmidt, Michael Hundemer
Published 2018-10-01
Article -
20
Prevalence of the GFI1-36N SNP in Multiple Myeloma Patients and Its Impact on the Prognosis by Cyrus Khandanpour, Christine Eisfeld, Subbaiah Chary Nimmagadda, Marc S. Raab, Niels Weinhold, Anja Seckinger, Dirk Hose, Anna Jauch, Asta Försti, Asta Försti, Asta Försti, Kari Hemminki, Kari Hemminki, Thomas Hielscher, Manuela Hummel, Manuela Hummel, Georg Lenz, Hartmut Goldschmidt, Hartmut Goldschmidt, Stefanie Huhn
Published 2021-10-01
Article